A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer
Clinical trial NCT00022672 · COMPLETED
Trial details
- NCT number
- NCT00022672
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Primary completion
- 2009-10-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.